David Hung - 29 Feb 2024 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Reporting relationship: PRESIDENT AND CEO, Director, 10%+ Owner
Issuer ticker: NUVB
Reported as of: 29 Feb 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Mar 2024, 16:20:13 UTC
Prior SEC filing: 09 Jun 2023
Next SEC filing: 06 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Ron A. Metzger, Attorney-in-Fact

Key filing fact

David Hung filed Form 4 for Nuvation Bio Inc. (NUVB) on 04 Mar 2024.

Key facts

This page summarizes David Hung's Form 4 filing for Nuvation Bio Inc. (NUVB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Mar 2024, 16:20.

Change

Previous filing in this sequence was filed on 09 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUVB transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +2,000,000
Change %
Price: $0.000000
Shares after: 2,000,000
Date: 29 Feb 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 2,000,000
Exercise price: $1.87
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.